Stephen Nadeau is a Neurology physician. ClinicalTrials.gov lists 3 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1600 SW Archer Road
Box 100371
Gainesville, FL 326100371
Telephone
352-273-5550Registry record last updated 19 Feb 2008.
Clinical trials
- Improving Stroke Rehabilitation: Spacing Effect and D-cycloserine
Sponsor: US Department of Veterans Affairs
- A Clinical Trial of Magnetic Stimulation in Depression
Sponsor: US Department of Veterans Affairs
- Strength Training and Stroke
Sponsor: US Department of Veterans Affairs
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
80.9%SSRI12.3%Trazodone Hcl48%Sertraline Hcl39%Citalopram Hbr7%Fluoxetine Hcl6%Part D<11 patientsBenzodiazepine7.3%Lorazepam55%Clonazepam33%Diazepam12%Part D<11 patients+ 19 more classes in this area
Metabolism & gastrointestinal
7%Serotonin-3 Receptor Antagonist3.1%Ondansetron Hcl65%Ondansetron Odt35%Part D<11 patientsProton pump inhibitor2.5%Omeprazole61%Pantoprazole Sodium39%Part D<11 patients+ 1 more class in this area
Musculoskeletal
5.4%Muscle Relaxant3.2%Carisoprodol65%Cyclobenzaprine Hcl35%Part D<11 patientsNonsteroidal Anti-inflammatory Drug1.4%Diclofenac Sodium100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2005–2005 per NIH RePORTER. The latest:
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Atte Meretoja
University of Helsinki
Bruce Miller, MD
University of California, San Francisco (UCSF)
Dennis Selkoe, MD
Brigham and Women's Hospital
Ettore Beghi
Mario Negri Institute for Pharmacological Research
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”